nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritodrine—PGD—Dacarbazine—skin cancer	0.964	1	CbGbCtD
Ritodrine—GALR3—female reproductive system—skin cancer	0.00415	0.215	CbGeAlD
Ritodrine—GALR3—head—skin cancer	0.00347	0.179	CbGeAlD
Ritodrine—PGD—nipple—skin cancer	0.00207	0.107	CbGeAlD
Ritodrine—PGD—neck—skin cancer	0.00205	0.106	CbGeAlD
Ritodrine—GALR3—Peptide GPCRs—MC1R—skin cancer	0.00187	0.114	CbGpPWpGaD
Ritodrine—PGD—connective tissue—skin cancer	0.00147	0.0761	CbGeAlD
Ritodrine—PGD—skin of body—skin cancer	0.00133	0.0687	CbGeAlD
Ritodrine—PGD—mammalian vulva—skin cancer	0.00121	0.0626	CbGeAlD
Ritodrine—PGD—lymphoid tissue—skin cancer	0.00108	0.0556	CbGeAlD
Ritodrine—PGD—female reproductive system—skin cancer	0.00104	0.0536	CbGeAlD
Ritodrine—ADRB2—Arf6 trafficking events—EXOC2—skin cancer	0.000998	0.0605	CbGpPWpGaD
Ritodrine—GALR3—Peptide ligand-binding receptors—MC1R—skin cancer	0.000882	0.0535	CbGpPWpGaD
Ritodrine—PGD—head—skin cancer	0.000867	0.0448	CbGeAlD
Ritodrine—GALR3—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.00069	0.0419	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—PTCH2—skin cancer	0.000623	0.0378	CbGpPWpGaD
Ritodrine—PGD—lymph node—skin cancer	0.000607	0.0314	CbGeAlD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.000591	0.0359	CbGpPWpGaD
Ritodrine—PGD—Carbohydrate metabolism—CSPG4—skin cancer	0.000553	0.0335	CbGpPWpGaD
Ritodrine—GALR3—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.000454	0.0275	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—MC1R—skin cancer	0.00045	0.0273	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.000389	0.0236	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—RHOU—skin cancer	0.000387	0.0235	CbGpPWpGaD
Ritodrine—PGD—Carbohydrate metabolism—ENO2—skin cancer	0.000376	0.0228	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—SHH—skin cancer	0.000321	0.0195	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PTCH2—skin cancer	0.00032	0.0194	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—SMO—skin cancer	0.000304	0.0185	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—PTCH1—skin cancer	0.000304	0.0185	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—PTGER4—skin cancer	0.000296	0.018	CbGpPWpGaD
Ritodrine—ADRB2—G alpha (s) signalling events—MC1R—skin cancer	0.000282	0.0171	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—MC1R—skin cancer	0.000255	0.0154	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Other—SMO—skin cancer	0.000244	0.0148	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—MC1R—skin cancer	0.000231	0.014	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PTCH2—skin cancer	0.000189	0.0115	CbGpPWpGaD
Ritodrine—ADRB2—G alpha (s) signalling events—PTGER4—skin cancer	0.000186	0.0113	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—PTGER4—skin cancer	0.000167	0.0102	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—SHH—skin cancer	0.000165	0.00999	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PLIN2—skin cancer	0.000163	0.00987	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.000157	0.00953	CbGpPWpGaD
Ritodrine—PGD—Disease—CSPG4—skin cancer	0.000157	0.0095	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PTCH1—skin cancer	0.000156	0.00947	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—SMO—skin cancer	0.000156	0.00947	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PTGER4—skin cancer	0.000152	0.00922	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GLI2—skin cancer	0.000143	0.00868	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—PTCH2—skin cancer	0.000142	0.0086	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MC1R—skin cancer	0.000137	0.00828	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.000135	0.00817	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GLI1—skin cancer	0.000135	0.00816	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CSPG4—skin cancer	0.000131	0.00796	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—SUFU—skin cancer	0.000128	0.00774	CbGpPWpGaD
Ritodrine—PGD—Disease—ENO2—skin cancer	0.000106	0.00646	CbGpPWpGaD
Ritodrine—PGD—Disease—SHH—skin cancer	0.000106	0.00646	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.000103	0.00627	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—MC1R—skin cancer	0.000103	0.00622	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—SHH—skin cancer	9.73e-05	0.0059	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—RASA1—skin cancer	9.67e-05	0.00586	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PTCH1—skin cancer	9.22e-05	0.00559	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—SMO—skin cancer	9.22e-05	0.00559	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PTGER4—skin cancer	8.98e-05	0.00545	CbGpPWpGaD
Ritodrine—PGD—Metabolism—ENO2—skin cancer	8.92e-05	0.00541	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	8.85e-05	0.00537	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—RHOU—skin cancer	8.8e-05	0.00534	CbGpPWpGaD
Ritodrine—PGD—Disease—FOXO4—skin cancer	8.68e-05	0.00526	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FOXO4—skin cancer	7.93e-05	0.00481	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—SHH—skin cancer	7.31e-05	0.00443	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PTCH2—skin cancer	7.28e-05	0.00441	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—PTCH1—skin cancer	6.93e-05	0.0042	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—SMO—skin cancer	6.93e-05	0.0042	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—PTGER4—skin cancer	6.74e-05	0.00409	CbGpPWpGaD
Ritodrine—PGD—Disease—ERCC2—skin cancer	6.19e-05	0.00375	CbGpPWpGaD
Ritodrine—PGD—Disease—TERT—skin cancer	5.8e-05	0.00352	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—MC1R—skin cancer	5.79e-05	0.00351	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TERT—skin cancer	5.3e-05	0.00321	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—MC1R—skin cancer	5.26e-05	0.00319	CbGpPWpGaD
Ritodrine—PGD—Metabolism—ERCC2—skin cancer	5.18e-05	0.00314	CbGpPWpGaD
Ritodrine—PGD—Disease—BRAF—skin cancer	4.59e-05	0.00278	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—NRAS—skin cancer	4.46e-05	0.00271	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTCH2—skin cancer	4.3e-05	0.00261	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—BRAF—skin cancer	4.2e-05	0.00254	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—KRAS—skin cancer	3.84e-05	0.00233	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PTGER4—skin cancer	3.81e-05	0.00231	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—SHH—skin cancer	3.75e-05	0.00227	CbGpPWpGaD
Ritodrine—PGD—Disease—PTGS2—skin cancer	3.71e-05	0.00225	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PTCH1—skin cancer	3.55e-05	0.00216	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—SMO—skin cancer	3.55e-05	0.00216	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PTGER4—skin cancer	3.46e-05	0.0021	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—HRAS—skin cancer	3.26e-05	0.00198	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GLI2—skin cancer	3.26e-05	0.00198	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—IL6—skin cancer	3.12e-05	0.0019	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MC1R—skin cancer	3.11e-05	0.00189	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PTGS2—skin cancer	3.11e-05	0.00188	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GLI1—skin cancer	3.06e-05	0.00186	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SUFU—skin cancer	2.9e-05	0.00176	CbGpPWpGaD
Ritodrine—PGD—Disease—NRAS—skin cancer	2.89e-05	0.00175	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NRAS—skin cancer	2.64e-05	0.0016	CbGpPWpGaD
Ritodrine—PGD—Disease—KRAS—skin cancer	2.48e-05	0.00151	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—KRAS—skin cancer	2.27e-05	0.00138	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SHH—skin cancer	2.21e-05	0.00134	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—RASA1—skin cancer	2.2e-05	0.00133	CbGpPWpGaD
Ritodrine—PGD—Disease—HRAS—skin cancer	2.11e-05	0.00128	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTCH1—skin cancer	2.1e-05	0.00127	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SMO—skin cancer	2.1e-05	0.00127	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTGER4—skin cancer	2.04e-05	0.00124	CbGpPWpGaD
Ritodrine—PGD—Disease—IL6—skin cancer	2.02e-05	0.00123	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TP53—skin cancer	2.02e-05	0.00122	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—HRAS—skin cancer	1.93e-05	0.00117	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IL6—skin cancer	1.85e-05	0.00112	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FOXO4—skin cancer	1.81e-05	0.00109	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TERT—skin cancer	1.21e-05	0.000731	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—NRAS—skin cancer	1.02e-05	0.000616	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—BRAF—skin cancer	9.55e-06	0.000579	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—KRAS—skin cancer	8.74e-06	0.00053	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—HRAS—skin cancer	7.43e-06	0.000451	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—IL6—skin cancer	7.11e-06	0.000431	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NRAS—skin cancer	6e-06	0.000364	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—KRAS—skin cancer	5.17e-06	0.000313	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TP53—skin cancer	4.59e-06	0.000278	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HRAS—skin cancer	4.39e-06	0.000266	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL6—skin cancer	4.2e-06	0.000255	CbGpPWpGaD
